I've added the emphasis...key points for me
1) Great additional data, adds to the set nicely.
2) CONSISTENCY, very important
3) Safety first - No AE's reported in last batch
4) Affirmation Q3 SAS Revenue (maybe modest, but still revenue) is possible in this area.
Ann: Consistent pain reduction and improvement in function data, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.020(4.76%) |
Mkt cap ! $178.8M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 46.0¢ | 42.0¢ | $347.2K | 796.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16968 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 12449 | 2 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |